Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
Clinical Pharmacology and Therapeutics|December 30, 2025
Optimizing Body Size-Based Dosing Approaches for Antibody-Drug ConjugatesAndrew B SyBing, Diane D WangClinical Pharmacology and Therapeutics|August 16, 2025
Re-Evaluation of Fixed Dosing Versus Body Size-Based Dosing Approaches for Large Molecule Therapeutics in AdultsAndrew B SyBing, Huili Chen, Diane D WangJournal of Clinical Pharmacology|January 25, 2011
Standardized visual predictive check versus visual predictive check for model evaluationDiane D Wang, Shuzhong ZhangActa Pharmacologica Sinica|September 25, 2012
Clinical pharmacology considerations in biologics developmentLiang Zhao, Tian-hua Ren, Diane D WangJournal of Clinical Pharmacology|September 7, 2019
Population Pharmacokinetics of Talazoparib in Patients With Advanced CancerYanke Yu, Chandrasekar Durairaj, Haihong Shi, et al.Clinical Pharmacokinetics|February 14, 2020
Effect of P-glycoprotein (P-gp) Inducers on Exposure of P-gp Substrates: Review of Clinical Drug-Drug Interaction StudiesMohamed Elmeliegy, Manoli Vourvahis, Cen Guo, et al.Cancer Chemotherapy and Pharmacology|February 17, 2017
Effect of food on the bioavailability of palbociclibAna Ruiz-Garcia, Anna Plotka, Melissa O'Gorman, et al.Journal of Clinical Pharmacology|January 15, 2011
Fixed dosing versus body size-based dosing of therapeutic peptides and proteins in adultsShuzhong Zhang, Rong Shi, Chunze Li, et al.Clinical Pharmacology and Therapeutics|December 6, 2021
Analysis of US Food and Drug Administration Oncology Approvals on the Characterization of Hepatic Impairment Effect and Dosing RecommendationsDerek Z Yang, Ali Alhadab, Kourosh Parivar, et al.Journal of Clinical Pharmacology|July 22, 2020
Discordance Between Child-Pugh and National Cancer Institute Classifications for Hepatic Dysfunction: Implications on Dosing Recommendations for Oncology CompoundsMohamed Elmeliegy, Derek Z Yang, Engie Salama, et al.Pageof 3